FDA declines to approve Valeant's plaque psoriasis lotion Ruby Khatun Khatun19 Jun 2018 9:45 AM ISTValeant Pharmaceuticals International Inc’s plaque psoriasis treatment did not get approval from U.S. health regulators, a setback for the company...
Novartis touts effectiveness, safety of autoimmune drug copies Medical Dialogues Bureau19 Jun 2018 9:30 AM ISTZURICH: Novartis touted safety and efficacy of its biosimilar copies of Johnson & Johnson's Remicade and Amgen Inc's Enbrel, citing a study it...
Temporary restraining order for Dr Reddys in US Ruby Khatun Khatun18 Jun 2018 3:04 PM ISTNew Delhi: Indian pharma major Dr Reddy's Laboratories said that a US District Court has issued a temporary restraining order on the sale and...
NCLT allows Fortis to withdraw amalgamation scheme Ruby Khatun Khatun18 Jun 2018 11:05 AM ISTNew Delhi: Fortis Healthcare said National Company Law Tribunal (NCLT) bench in Chandigarh has approved the withdrawal of the scheme of amalgamation...
Alembic Pharma receives EIR from USFDA Medical Dialogues Bureau18 Jun 2018 10:30 AM ISTNew Delhi: Drug firm Alembic Pharmaceuticals said it has received Establishment Inspection Report from the US health regulator for its formulation...
Bayer begins Rs 1.3K crore open offer process to buy up to 26 percent stake in Monsanto India Medical Dialogues Bureau18 Jun 2018 10:00 AM ISTGerman chemicals and pharma major Bayer group has launched the process for over Rs 1,300 crore open offer to acquire up to 26 percent additional stake...
Sanofi says on track to regain solid position in cancer drugs Ruby Khatun Khatun18 Jun 2018 9:30 AM ISTSanofi believes it can make a comeback and re-establish a leading position in the competitive cancer drug market on the back of its immunotherapy...
Cipla gets USFDAs final approval for generic Isuprel Medical Dialogues Bureau17 Jun 2018 1:34 PM ISTMumbai: Cipla, announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Isoproterenol Hydrochloride Injection...
Now only online application for New Drugs, FDC and SND: CDSCO tells Pharma Cos Ruby Khatun Khatun17 Jun 2018 10:43 AM ISTNew Delhi: Through a recent notification, Central Drugs Standard Control Organization, Directorate General of Health Services, Ministry of Health and...
Eli Lilly lupus treatment succeeds in mid-stage trial Ruby Khatun Khatun17 Jun 2018 10:41 AM ISTEli Lilly & Co said its drug to treat autoimmune disease lupus met the main goal of a mid-stage trial, positioning the drugmaker to begin a bigger...
Sanofi Plots Cancer Comeback With First New Drug in Years Medical Dialogues Bureau17 Jun 2018 10:41 AM ISTBloomberg: Sanofi was a spectator during the last wave of cancer breakthroughs. The French drugmaker is counting on its first new tumor drug in seven...
USFDA finds deficiencies in Mylan's generic Advair Ruby Khatun Khatun17 Jun 2018 9:41 AM ISTMylan NV said that U.S. health regulators were unable to approve its generic version of GlaxoSmithKline’s blockbuster inhaled lung drug Advair for the...
